List of Devices Companies in Switzerland - 22

1DROP saves lives through better faster near patient health monitoring. 1DROP enables personalized healthcare by providing actionable health information that is accessible to everyone everywhere. One drop of sample, a few minutes and you receive your diagnostic test results on your mobile phone. 1DROP makes this a reality: 1. 1DROP Chip, to which a drop of sample (usually blood) is applied; 2. 1DROP portable Analyser, which quantifies multiple biomarkers from the 1DROP Chip within minutes; 3. 1DROP App, which is synchronised with the 1DROP Cloud, and shares data with Electronic Health Records (EHR), streamlining clinical workflows by providing access to patient diagnostic results in real-time and anywhere.

Your Best Partner In Diagnostics 28 years of dedication has made us what we are today, one of the forerunners in the Indian diagnostics industry. The 2nd biggest Diagnostic Companies in India with a formidable Domestic and International presence for the entire range of Reagents and Equipment. Our Reagent range includes Biochemistry Kits, Serology Kits, Immunoturbidimetry Kits, Specialized Kits, Coagulation Reagents, Hematology Reagents and System Reagents for Fully Automated Clinical Chemistry Analyzers. We are an ISO 9001- 2008 and ISO 13485:2003 certified Company. We conform to GMP standards and have an FDA approved most modern manufacturing facility. We have been successful in obtaining CE Marking as well for all our products. We have formed a wholly owned Subsidiary Company in Switzerland called Agappe Diagnostics Switzerland GmbH to cater to the needs of the world market effectively. We are the sole distributors of companies such as Toshiba Medical Systems Corporation (Japan), Mindray (China), I-Sens (Korea) and many other giants in the diagnostic industry. Our Vision To Establish Globally As A Premier In-Vitro Diagnostic Corporation And To Be The Best Partner In The Diagnostic Field For The Welfare Of Mankind. Our Mission To Expand And Continuously Improve Our Products And Services With A World Class R&D Program And To Provide The Best Work Environment For Our Employees To Meet And Exceed Their True Potential And To Thrive In A World Of Excellence.

Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at www.alcon.com.

Artiria Medical is a Swiss neurovascular company that empowers catheters and guidewires, developing cutting-edge technologies to revolutionize the limits of neurointerventional procedures. Their medical device offers navigation in brain arteries and stroke treatment, allowing for the treatment of vascular diseases. The company has secured FDA clearance for their real-time, deflectable guidewire and has received funding to advance stroke treatment technology in Europe and the US.

Aspivix is a medical device company in women’s health, based in Switzerland, developing next-generation devices for gynecology. Our flagship product, Carevix™, is the world’s first suction cervical stabilizer clinically proven to reduce pain and bleeding associated with transcervical procedures commonly performed in gynecology, including IUD insertion, hysteroscopy, cervical biopsies, fertility treatments, and more. Carevix™ is a medical device that has received in 2023 FDA-clearance for the US market, as well as the CE-Mark for the European countries. Carevix™ study published in the international journal, Contraception, in March 2023 demonstrated superiority over the use of a single tooth tenaculum, reducing the pain by up to 73% and the bleeding by up to 83% in IUD insertions. More than 120 million women worldwide have procedures using the antiquated single-tooth tenaculum, an instrument invented over a century ago, without consideration of a woman's anatomy or pain, and yet it is still considered to be the standard of care in gynecology. At Aspivix, we think women deserve more. We are driven by our vision to make gynecology modern.

CIS Pharma is an independent pharmaceutical research and development company that was established in 1952. It is based in the Basel Area, Switzerland and focuses on developing next-gen immuno-conjugates, ADCs, and radioligand. The company also specializes in novel contact lens coating technology.

Endeavour Vision is a leading venture capital and growth equity advisory firm focusing on commercial-stage medtech and digital health companies. We support transformative healthcare technologies that provide superior clinical benefits for patients or bring significant efficiencies to health systems. Our team offers strategic and operational expertise and extensive international experience investing in companies in Europe and North America. We have a proven track record of successful exits with recently realized investments that include Relievant Medsystems, Vertiflex, and Symetis, as well as several IPOs. Endeavour Vision’s international investment teams are located in Geneva, Switzerland, Minneapolis, US and San Francisco, US.

Mathys is committed to motion worldwide. Founded in 1946, the company has been active in medical technology since 1958 and focuses on the development, manufacture and distribution of joint replacement products. The company's services include implants for hip, knee, shoulder and sports orthopaedics, and synthetic bone graft substitute. Headquartered in Bettlach, Switzerland, Mathys has development and production sites in Switzerland and Germany, as well as subsidiaries in 10 countries, and has been part of the US-based company Enovis™ since 2021. Enovis is committed to measurably improving patient outcomes by developing specialised solutions to clinical problems.

Exogems uses an FDA-approved medical device (Lipogems®) to produce exosomes from the mesenchymal stems cells in fat. They are developing methods for using these exosomes to deliver therapeutics.

Geistlich is a global leader dedicated to advancing regenerative medicine. Geistlich has been the world market leader in the field of regenerative dentistry for many years. In addition, Geistlich is committed to providing comprehensive support to clinicians in the field of regenerative medicine through scientific research, innovative developments as well as educational programs. Geistlich is a Swiss family-owned company with tradition since 1851. With 15 subsidiaries and 60 distributors, the company reaches around 90 markets and employs over 800 people. The ownership structure enables the company to plan long-term and to consistently develop innovative products. Geistlich Pharma AG continuously invests in developing its research and technology and relies on its qualified and specialized employees. Currently Geistlich Pharma is - the global market leader in regenerative dentistry - the leader in biological bone and cartilage regeneration - supplies drugs and medical devices in selected application areas

Helsinn is a global pharmaceutical company that builds, launches, and commercializes products to improve the quality of life for patients with cancer and chronic disease, with a focus on supportive care, oncology, and dermato-oncology. Founded in 1976, Helsinn has over 40 years of experience in the pharmaceutical industry, with an extensive network of long-standing trusted partners enabling a commercial presence in 190 countries. Helsinn Healthcare SA, headquartered in Lugano (Switzerland), oversees the activities of the three Helsinn Group’s subsidiaries (Helsinn Birex Pharmaceuticals Ltd., Helsinn Therapeutics (U.S.), Inc., Helsinn Pharmaceuticals (Beijing) Co., Ltd.), defining and implementing the Group’s strategy. Our mission is to champion and support patients with cancer and chronic diseases at every stage of their journey, by providing them with the best medications and solutions based on their needs and preferences. Follow our LinkedIn page to stay updated with news from Helsinn Group! If you are interested in joining us, please visit our website (www.helsinn.com): applications should only be submitted via the appropriate country portal, available under “Careers – Join us” website section. * This account shall only be used to share news concerning Helsinn. We would like to emphasize that due to the highly regulated nature of the pharma industry, we cannot engage with you online in any discussions concerning our or other companies’ products and/or services, and/or treatment options. It is best to hold such discussions and to seek guidance privately from your healthcare professional.

Aktiia, now trading under Hilo, was established in 2018 to transform how blood pressure is measured and therefore managed. Hilo is transforming blood pressure monitoring with cuffless, AI-powered technology that delivers continuous, accessible insights for individuals and healthcare professionals. Our foundation model is trained on billions of optical signals and hundreds of millions of readings from over 120,000 users—one of the largest datasets in the field. Backed by a multidisciplinary team with deep expertise in biomedical signal processing, Hilo has contributed to over 120 peer-reviewed publications and holds more than 35 patents. Headquartered in Switzerland, we’re expanding globally to redefine how blood pressure is measured and managed.

Kuros Biosciences is a biotechnology company that specializes in providing superior biologics for better spinal fusions.

Limula offers a unique technology supporting routine manufacturing of highly-personalised cell therapies. They provide a modular solution for on-demand cell and gene therapy manufacturing, addressing one of the biggest challenges in the field of medicine.

Loop medical is developing a painless blood collection technology compatible with existing laboratory infrastructure.

medmix is a global leader in high-precision delivery devices. We occupy leading positions in the healthcare, consumer and industrial end-markets. Our customers benefit from a dedication to innovation and technological advancement that has resulted in over 900 active patents. Our 15 production sites worldwide together with our highly motivated and experienced team of over 1'900 employees provide our customers with uncompromising quality, proximity and agility. medmix is headquartered in Baar, Switzerland. Our shares are traded on the SIX Swiss Exchange (SIX: MEDX). www.medmix.swiss

Novostia is a privately held medical device company developing an innovative artificial heart valve, designed for patients of any age, including children. Novostia endeavors to advance its technology to clinical trials and regulatory approvals to improve the quality of life of millions of people worldwide suffering from aortic and mitral valve disease. For more information please visite www.novostia.com

SamanTree Medical proposes a breakthrough innovation for checking complete tumor removal during surgery: the Histolog® Scanner. This novel imaging modality is a direct support during cancer surgery to achieve the common goal of improving patient quality of life by decreasing rates of re-operation. The team is fully dedicated to bringing the Gold Standard in the operating room, enabling margin assessment, in real time, at the histological detail. SamanTree Medical SA was founded in December 2014 and is a spin-off of the EPFL (Ecole Polytechnique Fédérale de Lausanne). linktr.ee/SamanTree

Our combined excellence in software development within the field of analytics allows us to drive real advancements in data management. We provide and develop high-quality and innovative vendor-agnostic software solutions that are highly compatible without compromising performance. By automating and digitalizing workflows for generating, analyzing, and utilizing scientific data, we help our customers achieve scientific results faster and more conveniently, enabling better and quicker decision-making.

SGS provides best-in-class contract development, testing, and manufacturing services to deliver high-quality, safe, and effective medicines to market. As a leading contract service organization for over 40 years, we support clients in discovery, clinical development & commercialization, research, product development, quality control testing, and manufacturing. We operate more than 25 worldwide facilities in 11 countries. Our scientific experts accelerate drug development using innovative techniq

United for global excellence in dentistry. Every vision has its story, and ours began more than 60 years ago. Since then, our innovations and achievements have become landmarks in dentistry worldwide. Straumann began as a family-owned institute, grew into a publicly-owned holding, and today comprises a number of leading and talented companies around the world. Our vision has always been to create more than just smiles, but lasting confidence for dentists, labs, patients, employees, partners, dental networks and the global community.

Ypsomed is the leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist. The company will celebrate its 40th anniversary in 2024. As a leader in innovation and technology, it is a preferred partner of pharmaceutical and biotech companies for pens, autoinjectors and pump systems for administering liquid medications. Ypsomed presents and markets its product portfolios under the umbrella brand mylife Diabetescare directly to patients, pharmacies and hospitals as well as under Ypsomed Delivery Systems in business-to-business operations with pharmaceutical companies. Ypsomed is headquartered in Burgdorf, Switzerland. The company has a global network of production facilities, subsidiaries and distribution partners. Ypsomed has over 2,200 employees worldwide.